Introduction to Tarceva (Erlotinib) 100mg 

Erlocent (Erlotinib) 100mg is a prescription medicine used to treat certain types of cancer, particularly non-small cell lung cancer (NSCLC) and pancreatic cancer.
Erlocent (Erlotinib) 100mg is classified under Prescription Medicines, Oncology Drugs, Targeted Cancer Therapies, and Oral Anticancer Medications. It contains Erlotinib, which works by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase, helping to block cancer cell growth and proliferation.
In global markets, Tarceva is the original brand containing the same active ingredient, providing similar therapeutic benefits when prescribed by a qualified healthcare professional.

What Is Tarceva (Erlotinib)? 

Tarceva is the brand name for Erlotinib, an oral targeted therapy widely used in oncology for treating EGFR-positive cancers.
Erlotinib is classified as a tyrosine kinase inhibitor (TKI), which works by blocking signals that promote cancer cell growth.
Generic versions such as Erlocent 100mg contain the same active compound and may be used depending on physician recommendation and availability.

Drug Class and Mechanism of Action 

Erlotinib is classified as an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with potent antineoplastic activity.

How Erlotinib Works 

It works in several ways:

• Inhibits EGFR tyrosine kinase activity in cancer cells
• Blocks downstream signaling that promotes tumor growth
• Induces apoptosis (cell death) in cancerous cells

Through these mechanisms, Erlotinib helps slow cancer progression and improve patient outcomes.

How Tarceva Works in the Body 

Erlotinib is absorbed orally and inhibits EGFR signaling in tumor cells, reducing cell proliferation and survival.

Key Actions of Erlotinib 

• Reduces tumor cell growth
• Helps shrink existing tumors
• Slows progression of EGFR-positive cancers
  Generic versions like Erlocent provide similar therapeutic effects when prescribed appropriately.

Medical Uses of Tarceva (Erlotinib) 100mg 

Erlocent 100mg is primarily prescribed for certain cancers with EGFR mutation or expression.

Tarceva for Non-Small Cell Lung Cancer (NSCLC) 

Used for first-line or subsequent therapy in patients with EGFR-positive NSCLC.

Potential Benefits 

• Reduced tumor growth
• Improved progression-free survival
• Better symptom control

Tarceva for Pancreatic Cancer 

Used in combination with gemcitabine for advanced pancreatic cancer.

Treatment Benefits 

• Slows tumor progression
• Improves overall survival in combination therapy
• Helps manage cancer-related symptoms

Who Can Take Erlocent 100mg? 

This medicine should be used under strict oncology supervision.

Eligibility Criteria 

Patients may be prescribed Tarceva if they:

• Have confirmed EGFR-positive NSCLC or pancreatic cancer
• Can tolerate oral targeted therapy
• Have been evaluated for liver and kidney function

Generic options such as Erlocent may also be considered depending on availability.

Who Should Avoid Tarceva (Erlotinib) 100mg 

This medicine should NOT be used by:

• Patients with known hypersensitivity to Erlotinib
• Pregnant or breastfeeding women
• Individuals with severe liver impairment
• Patients taking certain medications that strongly interact with Erlotinib

Tarceva (Erlotinib) 100mg Dosage and Administration 

Standard Dosage Guidelines 

Typical dosage recommendations include:

• Erlocent 100mg once daily, orally
• Take on an empty stomach at least 1 hour before or 2 hours after meals
• Swallow tablets whole with water

Dosage Adjustments 

Doctors may adjust the dose depending on:

• Tolerability and side effects
• Liver function
• Concomitant medications

Side Effects of Erlocent 100mg 

Like all cancer medicines, it may cause side effects.

Common Side Effects 

• Rash or acne-like skin changes
• Diarrhea
• Fatigue
• Loss of appetite

Serious Side Effects 

• Severe liver toxicity
• Interstitial lung disease (rare)
• Severe allergic reactions
  Patients should report serious or unusual symptoms to their doctor immediately.

Storage:
Store below 25°C in a cool, dry place, protected from moisture and sunlight. Keep out of reach of children.

Frequently Asked Questions (FAQs) 

1. Is Tarceva (Erlotinib) 100mg safe for long-term use? 

Long-term use is possible under oncology supervision with regular monitoring of liver function and side effects.

2. Can Erlocent 100mg be taken with food? 

It is recommended to take it on an empty stomach for optimal absorption.

3. Can pregnant women take Erlotinib? 

No, it is contraindicated during pregnancy due to potential harm to the fetus.

4. Is Erlocent 100mg the same as Tarceva? 

Yes, it contains Erlotinib, the same active ingredient as Tarceva.

5. Do I need a prescription to buy Erlocent 100mg? 

Yes, it is a prescription-only oncology medicine.

Medical Disclaimer 

Disclaimer:
The information provided here is for educational purposes only and should not be considered medical advice. This medicine should be used strictly under the supervision of a qualified oncologist. Always consult your doctor before starting, stopping, or changing any medication.